Literature DB >> 29916026

Acute Kidney Injury Due to Diarrheal Illness Requiring Hospitalization: Data from the National Inpatient Sample.

Christina Bradshaw1, Yuanchao Zheng2, Samuel A Silver3, Glenn M Chertow2,4, Jin Long2, Shuchi Anand2.   

Abstract

BACKGROUND: Diarrheal illness is a major reason for hospitalization, but data on consequent acute kidney injury (AKI) are sparse.
OBJECTIVE: To determine the incidence of AKI in infectious and non-infectious diarrheal illness requiring hospitalization and to identify correlates and outcomes of diarrhea-associated AKI.
DESIGN: Using data from the 2012 National Inpatient Sample (NIS), we created a cohort of patients with a primary diagnosis of diarrheal illness. Diarrheal illness, disease correlates, and AKI were defined by ICD-9 diagnosis codes. We used logistic regression with backward variable selection to determine factors independently associated with AKI in infectious and non-infectious diarrheal illness, as well as to determine the association of AKI with in-hospital mortality. We used generalized linear models to assess differences in length of stay and costs of hospitalization. MAIN MEASURES: The primary outcome was AKI in hospitalized diarrheal illness. Secondary outcomes were in-hospital mortality, length of stay, and cost of hospitalization associated with AKI. KEY
RESULTS: One in ten adults hospitalized with diarrheal illness experienced AKI, with higher incidence rates in older adults. Chronic kidney disease (CKD) and hypertension were associated with increased odds of AKI (all diarrhea OR 4.81, 95% CI 4.52 to 5.12 and OR 1.33, 95% CI 1.27 to 1.40, respectively). AKI in diarrheal illness was associated with substantial increase in mortality (OR 5.05, 95% CI 4.47 to 5.72), length of stay (mean increase 1.7 days [95% CI 1.6 to 1.8]), and cost of hospitalization (mean increase $4411 [95% CI 4023 to 4800]).
CONCLUSION: Acute kidney injury is common and consequential among patients hospitalized for diarrheal illness. Persons with CKD and hypertension are the most susceptible, possibly due to diminished renal reserve and exacerbating effects of treatment with diuretics and renin-angiotensin-aldosterone system blockers. Proactive management of these unique pharmacologic and physiologic factors is necessary to prevent AKI in this vulnerable population.

Entities:  

Keywords:  clinical epidemiology; hospital medicine; prevention; renal disease

Mesh:

Year:  2018        PMID: 29916026      PMCID: PMC6109014          DOI: 10.1007/s11606-018-4531-6

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  35 in total

1.  Performance and limitations of administrative data in the identification of AKI.

Authors:  Morgan E Grams; Sushrut S Waikar; Blaithin MacMahon; Seamus Whelton; Shoshana H Ballew; Josef Coresh
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

Review 2.  Role of angiotensin converting enzyme inhibitors in essential and renal hypertension. Effects of captopril and enalapril on renin-angiotensin-aldosterone, renal function and hemodynamics, salt and water excretion, and body fluid composition.

Authors:  J H Bauer
Journal:  Am J Med       Date:  1984-08-20       Impact factor: 4.965

3.  Trends in Hospitalization for Diverticulitis and Diverticular Bleeding in the United States From 2000 to 2010.

Authors:  Chelle L Wheat; Lisa L Strate
Journal:  Clin Gastroenterol Hepatol       Date:  2015-04-08       Impact factor: 11.382

4.  Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome.

Authors:  Eric A J Hoste; Norbert H Lameire; Raymond C Vanholder; Dominique D Benoit; Johan M A Decruyenaere; Francis A Colardyn
Journal:  J Am Soc Nephrol       Date:  2003-04       Impact factor: 10.121

5.  Burden of Clostridium difficile infection in the United States.

Authors:  Fernanda C Lessa; Yi Mu; Wendy M Bamberg; Zintars G Beldavs; Ghinwa K Dumyati; John R Dunn; Monica M Farley; Stacy M Holzbauer; James I Meek; Erin C Phipps; Lucy E Wilson; Lisa G Winston; Jessica A Cohen; Brandi M Limbago; Scott K Fridkin; Dale N Gerding; L Clifford McDonald
Journal:  N Engl J Med       Date:  2015-02-26       Impact factor: 91.245

6.  Influence of renal dysfunction on mortality after cardiac surgery: modifying effect of preoperative renal function.

Authors:  Charuhas V Thakar; Sarah Worley; Susana Arrigain; Jean-Pierre Yared; Emil P Paganini
Journal:  Kidney Int       Date:  2005-03       Impact factor: 10.612

7.  Temporal Trends in the Incidence and Natural History of Diverticulitis: A Population-Based Study.

Authors:  Adil E Bharucha; Gopanandan Parthasarathy; Ivo Ditah; J G Fletcher; Ofor Ewelukwa; Rajesh Pendlimari; Barbara P Yawn; L Joseph Melton; Cathy Schleck; Alan R Zinsmeister
Journal:  Am J Gastroenterol       Date:  2015-09-29       Impact factor: 10.864

8.  Heart failure–associated hospitalizations in the United States.

Authors:  Saul Blecker; Margaret Paul; Glen Taksler; Gbenga Ogedegbe; Stuart Katz
Journal:  J Am Coll Cardiol       Date:  2013-03-26       Impact factor: 24.094

9.  Comorbidity profiles and inpatient outcomes during hospitalization for heart failure: an analysis of the U.S. Nationwide inpatient sample.

Authors:  Christopher S Lee; Christopher V Chien; Julie T Bidwell; Jill M Gelow; Quin E Denfeld; Ruth Masterson Creber; Harleah G Buck; James O Mudd
Journal:  BMC Cardiovasc Disord       Date:  2014-06-05       Impact factor: 2.298

Review 10.  Prevention and management of acute kidney injury.

Authors:  John Harty
Journal:  Ulster Med J       Date:  2014-09
View more
  2 in total

1.  Acute Kidney Injury in Children Hospitalized With Diarrheal Illness in the United States.

Authors:  Christina Bradshaw; Jialin Han; Glenn M Chertow; Jin Long; Scott M Sutherland; Shuchi Anand
Journal:  Hosp Pediatr       Date:  2019-12

2.  Campylobacter-associated hospitalisations in an Australian provincial setting.

Authors:  Cameron R M Moffatt; Karina J Kennedy; Linda Selvey; Martyn D Kirk
Journal:  BMC Infect Dis       Date:  2021-01-06       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.